
Browsing restrictions can be lifted for a fee.
Favite, Inc. engages in the manufacture and sale of general and precision instruments, and telecommunication control frequency equipment. The company offers panel display inspection equipment, such as array high resolution, CF high-resolution, touch panel, and Mura defect automatic optical inspection equipment, as well as automatic optical appearance and display mask inspection equipment, high-speed automatic optical camera, and automatic optical CD measuring equipment; semiconductor optical inspection equipment, die cutting after cutting appearance inspection machines, and multifunctional optical microscope systems; multilayer RDL fine line defect inspection machine; automatic defect classification and judgment systems; and yield management systems. It also offers information software services. The company was founded in 1999 and is based in Zhubei, Taiwan.
3535
晶彩科
-11.11%
(-0.11)
The most recent financial report for 晶彩科 (3535) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3535's short-term business performance and financial health. For the latest updates on 3535's earnings releases, visit this page regularly.
According to the latest financial report, 晶彩科 (3535) reported an Operating Profit of -15.6M with an Operating Margin of -14.15% this period, representing a growth of 22.29% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 晶彩科 (3535) announced revenue of 110.29M, with a Year-Over-Year growth rate of -8.6%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 晶彩科 (3535) held Total Cash and Cash Equivalents of 170.25M, accounting for 0.1 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 晶彩科 (3535) did not achieve the “three margins increasing” benchmark, with a gross margin of 46.91%%, operating margin of -14.15%%, and net margin of -3.89%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3535's profit trajectory and future growth potential.
According to the past four quarterly reports, 晶彩科 (3535)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
晶彩科 (3535)'s Free Cash Flow (FCF) for the period is 2.38M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 86.62% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.